Brunei vs Portugal: Cause of death, by non-communicable diseases, ages 0-4, male
Brunei
47.9%
in 2021
Portugal
47.5%
in 2021
Brunei rank
15th
Portugal rank
16th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Brunei
- Portugal
How they compare
Brunei currently reports 47.9% against 47.5% in Portugal, a difference of 0.4%.
Across all 6 years both countries report, Brunei has been ahead every year.
Brunei ranks 15th and Portugal ranks 16th of 185 countries.
Brunei has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.5% | 47.1% | 5.3% | Brunei |
| 2010s | 51.4% | 42.2% | 9.2% | Brunei |
| 2020s | 47.8% | 47.0% | 0.8% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Brunei or Portugal?
- Brunei, at 47.9% against 47.5% in Portugal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Brunei and Portugal?
- 0.4%, with Brunei ahead.
- How many years of comparable data are there for Brunei and Portugal?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Portugal rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Brunei ranks 15th and Portugal ranks 16th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.